ReviewAnnals of the rheumatic diseases2000

Treatment of spondyloarthropathies with antibodies against tumour necrosis factor alpha: first clinical and laboratory experiences.

J Braun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.